Global PCR Machine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global PCR Machine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

PCR Machine is a machine that amplifies and detects DNA. Scientists in all areas of life science — basic research, biotechnology, medicine, forensics, diagnostics, and more — utilize these machines in a wide range of applications. PCR machines can be used for both qualitative and quantitative analysis.

Market Overview:

The latest research study on the global PCR Machine market finds that the global PCR Machine market reached a value of USD 1739.2 million in 2022. It’s expected that the market will achieve USD 2847.08 million by 2028, exhibiting a CAGR of 8.56% during the forecast period.

Influence of COVID-19 Outbreak on PCR Machine Industry Development

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to nearly 100 countries around the world, and the World Health Organization has declared it an emergency public health event. The COVID-19 epidemic is infected with a large number of people, and its spread and scope far exceed SARS. At present, the number of confirmed cases in Worldwide has exceeded 18 million. Different industries are affected differently by the epidemic situation.

The impact on the general manufacturing industry is mainly reflected in the supply of raw materials and the demand of the downstream market. Affected by the new crown pneumonia epidemic, logistics will be suspended and the supply of raw materials will be tight. Due to the global threat of COVID-19, the resumption of global factories will directly affect customers' production plans and delivery plans. The continuous outbreak of the international epidemic will affect the smooth supply of equipment and materials if the personnel control of various countries is expanded.

But because PCR Machine is of great significance for the detection of COVID-19 virus, PCR is one of the most widely used diagnostic tests for detecting pathogens (including viruses) of diseases including Ebola virus, African swine fever and foot-and-mouth disease. Since the COVID-19 virus only contains RNA, it can be detected using real-time or conventional RT-PCR. Therefore, due to the impact of this epidemic, the demand for PCR Machine has increased.

Real-time RT-PCR is significantly faster, and the possibility of contamination or errors is lower because the entire process can be performed in a closed test tube. It is still the most accurate method available to detect the COVID-19 virus. And it provides advantages including automation, higher-throughput, and more reliable instrumentation. It has become the preferred method. In addition, during the epidemic, many companies provide product support in the fight against COVID-19, such as June 2020 According to a related report on the 18th, Bio-Rad Laboratories, Inc. continues to support the global fight against the SARS-CoV-2 virus COVID-19 disease. The company provides instruments, tests and its SARS-CoV-2 standard to help laboratories verify their COVID-19 analysis results and speed up testing. From another perspective, this will also establish a good brand image for the company to help follow-up development.

Equipment replacement brings new development opportunities

In some developing Chinese countries, with the continuous improvement of medical construction, the replacement of equipment in primary hospitals has brought new opportunities in the market, the instrument end has accelerated import substitution, and the reagent end has increased in the product line. For example, in China, although foreign giants of high-end PCR instruments in tertiary hospitals still dominate, domestic mainstream application technology platforms have achieved independent production, and instrument performance has been comparable to imported products. With the cancellation of medical reform policies such as drug markups, medical insurance control fees, graded diagnosis and treatment, and domestic medical equipment procurement support policies, it is expected to start a new round of domestic substitution process from the bottom up.

Regional medical device policy restrictions

There is no doubt that PCR Machine, as a technical product, have many advantages and is more expensive than ordinary medical equipment. This may be difficult for countries or regions where there is no medical reimbursement or a small percentage of reimbursement.
Secondly, PCR Machine based on electronic technology, so for new entrants, if they want to enter the industry, they should have sufficient funds and technical reserves.

Expensive installation costs and its complexity

On the other hand, expensive installation charges and complexity in providing favorable conditions for the amplification of DNA might hamper the growth of the market.

Region Overview:

Geographically, North America held the largest market share – 49.53% in 2022.

Company Overview:

Thermo Fisher is one of the major players operating in the PCR Machine market, holding a share of 21.72% in 2023.

Thermo Fisher

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.

Roche

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Segmentation Overview:

As for product types, the Real Time segment held the largest market share in 2022.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2018 to 2022.

Key Companies in the global PCR Machine market covered in Chapter 3:

Esco
Roche
Qiagen
Fluidigm
Agilent
Bio-Rad
Sigma-Aldrich
Takara
Eppendorf
Thermo Fisher
Bioer
Analytik Jena

In Chapter 4 and Chapter 14.2, on the basis of types, the PCR Machine market from 2018 to 2029 is primarily split into:

Real Time
Standard
Digital
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the PCR Machine market from 2018 to 2029 covers:

Universities
Hospitals
Labs
CDC
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)